Krista McKerracher

Krista McKerracher is a biopharmaceutical leader, Board member and strategic advisor with 35 years’ experience in both large global pharmaceutical and small biotech companies. Her last corporate role was VP, Head of Hemoglobinopathy Programs at CRISPR Therapeutics where she and her team took the first CRISPR gene-edited product into the clinic. Prior to CRISPR Therapeutics she was VP & Global Program Franchise Head of Novartis where she led a global cross-functional development team.